person
as of 2026-07-01Renrong Wu, Prof
Renrong WuRenrong Wu, MD
at a glance
Roles: Principal Investigator, Study Chair, Author
KOL signal score 10
2 publications · 1 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
The Second Xiangya Hospital of Central South University Psychiatry Department
Roles
Principal Investigator, Study Chair, Author
KOL signal
10
Publications
2 (1 high-value)
Trial investigator
yes
Publishes on
1 drugs
Trials led
4
Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients
NCT07045142Phase 3Recruiting
iTBS on Negative Symptoms and Cognitive Function in Schizophrenia
NCT05137158—Completed
rTMS on Appetite and Cognitive Function in Schizophrenia
NCT04714970—Unknown
Metformin for Treatment of Antipsychotic-induced Dyslipidemia
NCT01778244Phase 4Completed
Publications & congress
2
Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial.
BMC medicine · 2023 · high-value
Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.
Psychiatry research · 2023
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
drug
STUDY_CHAIR